Home

About Us

Pharma-Free CME

Resources by Topic

Resources by Type

Teaching Tools

Drug Industry

Contact Us

How You Can Help

RSS NEWS FEED

Home

PharmedOut is an independent, publicly funded project that empowers physicians to identify and counter inappropriate pharmaceutical promotion practices. PharmedOut promotes evidence-based medicine by providing news, resources, and links to pharma-free CME courses.

Pharma-Free CME

More than 200 free web-based CME credits are available without cost.

Resources by Topic

Drug promotion, drug information, evidence-based
medicine, docs and pharma, industry-sponsored research, conflict of interest, direct-to-consumer advertising, drug reps, and other topics.

Resources by Type

Articles, reports, slide shows, databases, subscribables, and links to other organizations and websites.

Teaching Tools

No Drug Reps Certificate, Drug Ad Bingo, and other materials for educators.

---

PharmedOut Publications

PharmedOut in the Media

News Archive

How You Can Help

Our Videos



Pharma Insider II
Opposition research
(read transcript)

---

Pharma Insider I
Off-label promotion under the radar
(read transcript)

---

The Art of Medical Writing
Pharma's anonymous writers

---

Drug Reps Talk Shop II
Drug reps continue their chat

---

Drug Reps Talk Shop I Selling drugs to docs

---

Director of PharmedOut Explains the Project

---

Zyprexa Drug Rep Tells All Shahram Ahari describes how he sold the drug

---

News

Analysis Finds Vioxx's Heart Attack Risk in 2001
35% increase in CV events WSJ

---

States, Consumer Advocates Challenge Rx Data Mining
FDA has been silent Chicago Tribune

---

Researcher Seeks New Treatments in Old Drugs
Bioinformatics promising Houston Chronicle

---

Some Doctors Say No More Free Lunches
“Goodies” are a conflict of interest Rapid City Journal

---

Study Raises Questions About Cholesterol Drug’s Benefit
Niacin bests Zetia NYT

---

Drug Makers Raise Prices in Face of Health Care Reform
Wholesale prices up 9% NYT

---

Unpublished Clinical Trials with Sumatriptan
Drug less effective Lancet (read commentary)

---

In House, Many Spoke With One Voice: Lobbyists’
Ghostwritten remarks underwritten by Genentech NYT

---

Health-Bill Disclosure Rule Is Resisted
CME funding at issue WSJ

---

Generic-Drug Makers Protest Supply Limits
FTC examines pharma practices
WSJ

---

At Top Schools, More Than Half the Profs Have Industry Ties
50 NIH-funded institutions surveyed WSJ Health Blog (read study and comments)

---

Commentary

Mammography and the Corporate Breast
Conflicts of USPSTF critics not mentioned Bioethics Forum

---

Click HERE to read the entire news archives